Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors

Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors

Corbus Pharmaceuticals, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the appointment of George Golumbeski, Ph.D., to its Board of Directors. Read more >>

Share this post